Phase Holographic

The HoloMonitor CellSync is the first in a series of models aimed at creating a clinical-grade product for automated quality control in cell and gene therapy manufacturing. This series will feature advancements in image processing and AI. Produced by a partner according to ISO 9001 standards, the HoloMonitor CellSync offers non-invasive, real-time imaging of live cells, building on previous technology with an updated camera and improved cell segmentation. Ivan Jurković, CEO of Phase Holographic Imaging, states that the company is on track to finalize a clinically applicable version by the second half of 2025. For more information, contact Ivan Jurković via email or visit the company's website.

Anders Månsson will step down as CEO of PHI immediately and will help with the transition process. Ivan Jurkovic, a PHI board member and CFO of Altium, will act as interim CEO during the recruitment period. Peter Egelberg, a founding board member and former CEO of PHI, will focus on product development and technical matters. Anders Månsson mentioned that his role as CEO was intended to be temporary and acknowledged Altium's increased involvement due to their larger stake in the company. Chairman Goran Dubravcic appreciated Anders' contributions during a transformative period for PHI and noted that the company will set a new direction following a recent share issue. Ivan Jurkovic, born in 1984, is an experienced financial executive with a background in various industries and currently serves as CFO at Altium SA. This information was released in compliance with the EU Market Abuse Regulation.